bims-micgli Biomed News
on Microglia
Issue of 2026–04–05
thirty-two papers selected by
Matheus Garcia Fragas, Universidade de São Paulo



  1. Cell Rep. 2026 Mar 27. pii: S2211-1247(26)00239-1. [Epub ahead of print]45(4): 117161
      High-expression variants of the complement C4 gene increase schizophrenia (SZ) risk. C4 overexpression (C4-OE) in the mouse frontal cortex recapitulates SZ-associated phenotypes, including lower synapse density, but the underlying mechanisms remain unclear. In the complement cascade, C4 is upstream of C3, whose cleavage fragments can bind complement receptors, including CR3, selectively expressed by microglia in the brain parenchyma. Therefore, we hypothesize that microglial CR3 mediates C4-OE effects. We show that C4-OE alters synapse density and function and that these effects are rescued in CR3-deficient mice. Contrary to the models of excessive microglia-mediated synaptic elimination, our previous results indicate that C4-OE reduces spine formation and elimination. Here, using in vivo two-photon imaging, we find that C4-OE decreases microglial surveilled volume, motility, and the frequency of microglial contacts with pre- and postsynaptic structures. These changes are abolished by CR3 deficiency. Our findings suggest that CR3-mediated modulation of microglia-synapse interactions underlies C4-OE effects relevant to SZ.
    Keywords:  CP: neuroscience; complement; in vivo two-photon; microglia; microscopy; mouse cortex; schizophrenia; synapse; synaptic pruning; synaptic refinement; synaptic remodeling
    DOI:  https://doi.org/10.1016/j.celrep.2026.117161
  2. Neuron. 2026 Apr 01. pii: S0896-6273(26)00175-3. [Epub ahead of print]
      Recent human genetic studies have highlighted the potential role of microglial genes and their regulatory functions in the pathogenesis of Alzheimer's disease (AD). The transcription factor PU.1 (encoded by SPI1) is expressed mainly in microglia in the central nervous system and has been reported to be a genetic risk factor for AD. However, the role of microglial SPI1 in AD etiology is still poorly understood. Here, we demonstrate that the selective deletion of Spi1 in microglia exacerbates AD-related pathologies in an amyloid mouse model. Specifically, microglial Spi1 deletion increases amyloid deposition, gliosis, and dystrophic neurites while decreasing the microglial response to plaques. By combining proteomics and functional analyses, we reveal that the loss of microglial Spi1 impairs phagocytosis through Syk, Lyn, and Fcgr1. Furthermore, directly activating these genes rescues the impaired amyloid-beta (Aβ) uptake caused by Spi1 knockdown, unveiling the potential mechanism of SPI1 in amyloid pathology.
    Keywords:  Alzheimer’s disease; Fcgr1; Lyn; PU.1; SPI1; Syk; amyloid; amyloidosis; microglia; phagocytosis
    DOI:  https://doi.org/10.1016/j.neuron.2026.03.011
  3. Immunity. 2026 Mar 31. pii: S1074-7613(26)00121-4. [Epub ahead of print]
      Glioblastoma (GB) cells infiltrate the brain parenchyma and colonize distant regions, driving recurrence and therapy resistance. Here, we examined dynamic microglial responses to infiltrating tumor cells during GB progression. Three-photon imaging in an autochthonous, immunocompetent GB mouse model enabled visualization of microglia-GB interactions at the far infiltration zone (FIZ) in the corpus callosum (CC). GB infiltration speed varied by anatomical location and tumor microtube (TM) number. Microglia increased surveillance in sparsely infiltrated areas but reduced it with higher GB density, revealing a biphasic response. Directional migration toward GB cells was restricted to microglial subsets within a defined spatial range, indicating heterogeneous reactivity. CX3CR1 deficiency enhanced microglial reactivity while limiting GB cell migration. Microglia depletion with the CSF1R inhibitor PLX5622 reduced GB cell migration and constrained TM plasticity. Thus, microglia respond to GB cell infiltration in a stage-dependent manner and critically modulate dissemination at the FIZ.
    Keywords:  CSF1R inhibition; CX3CR1-deficiency; Corpus callosum; autochthonous mouse model; diffuse infiltration; glioblastoma; microglia; migration; motility; three-photon microscopy; tumor microtubes
    DOI:  https://doi.org/10.1016/j.immuni.2026.03.010
  4. J Neurochem. 2026 Apr;170(4): e70416
      Neuroinflammation plays a fundamental role in several neurodegenerative diseases, including Alzheimer's disease (AD), the leading cause of dementia worldwide. As the main defense response of the central nervous system (CNS), neuroinflammation can be either protective or detrimental depending on the stage of the disease. The pivotal role of neuroinflammation in AD has led to increasing investigations into neuroinflammatory mechanisms, aiming to develop AD-modifying therapies. A significant advance in the field was the emergence of the human induced pluripotent stem cell (hiPSC) model, enabling the study of patient-derived cells. Moreover, the development of hiPSC-derived brain organoids, which mimic specific aspects of the human CNS, has expanded our understanding of neuroinflammation in AD. Here, we review how AD organoid models have evolved, focusing on the integration of microglia-the brain's primary immune surveillance cells. We also summarize recent findings on how glial activation and the crosstalk between microglia and other CNS cells affect AD progression. Lastly, we address the potential of hiPSC-derived organoids as a preclinical model for screening AD drugs.
    Keywords:  Alzheimer's disease; astrocytes; cerebral organoid; human induced pluripotent stem cells; microglia; neuroinflammation
    DOI:  https://doi.org/10.1111/jnc.70416
  5. Nat Commun. 2026 Mar 31. pii: 2699. [Epub ahead of print]17(1):
      Tau accumulates in a group of neurodegenerative diseases known as tauopathies. A prevailing hypothesis has been that Tau degradation is impaired due to an age-related imbalance in the autophagy-lysosome pathway, but whether these defects are a cause or consequence of Tau accumulation remains unclear. Here we show that a disease-causing mutation in the MAPT gene, which encodes Tau, p.R406W, is sufficient to disrupt multiple steps of the autophagy-lysosome pathway in human neurons. Using Airyscan super-resolution imaging, we find that mutant Tau neurons accumulate Tau and phosphorylated Tau in dysfunctional lysosomes, exhibit reduced lysosome motility, impaired fusion of autophagosomes and lysosomes, and increased undegraded cellular cargo. Pharmacological enhancement of autophagy improves cargo clearance and lowers Tau levels, without restoring defects in lysosomal motility. Together, these findings demonstrate that mutant Tau directly perturbs cellular clearance pathways and suggest that boosting autophagy may help restore Tau homeostasis in tauopathies.
    DOI:  https://doi.org/10.1038/s41467-026-70473-5
  6. Neurotherapeutics. 2026 Mar;pii: S1878-7479(26)00061-9. [Epub ahead of print]23(2): e00891
      
    Keywords:  Epigenetic regulation; Glial scar; Innovative therapy; Lipid metabolism; Microglia; Spinal cord injury
    DOI:  https://doi.org/10.1016/j.neurot.2026.e00891
  7. STAR Protoc. 2026 Apr 01. pii: S2666-1667(26)00124-3. [Epub ahead of print]7(2): 104471
      Microglia are the resident macrophages of the central nervous system and are highly sensitive to environmental cues, making primary culture challenging. Here, we present a protocol for isolating microglia from adult mouse brains using magnetic-activated cell sorting (MACS). The protocol includes brain sample collection, enzymatic tissue dissociation, step-by-step MACS-based microglia isolation, and the establishment of primary microglial cultures. We validate isolated cells using flow cytometry and quantitative real-time PCR (real-time qPCR) to assess microglial purity.
    Keywords:  Cell culture; Cell isolation; Cell separation/fractionation; Cell-based Assays; Neuroscience
    DOI:  https://doi.org/10.1016/j.xpro.2026.104471
  8. Ageing Res Rev. 2026 Mar 26. pii: S1568-1637(26)00106-6. [Epub ahead of print] 103114
      Lipid metabolism plays a crucial role in maintaining brain homeostasis, affecting energy balance, membrane structure, and signaling pathways essential for neuronal and glial health. Disruption of lipid pathways is linked to neuroinflammation and the progression of neurodegenerative diseases like Alzheimer's and Parkinson's, as well as aging. Changes in cholesterol trafficking, sphingolipid and ceramide metabolism, and phospholipid remodeling can compromise synaptic membrane integrity and signaling, thereby increasing oxidative stress and inflammatory responses. Advanced techniques such as single-cell RNA sequencing (scRNA-seq) and single-nucleus transcriptomics have revealed specific alterations in lipid metabolism across different cell types, indicating a metabolic shift that enhances microglial activation and astrocytic reactivity. This lipid dysregulation contributes to a cycle that heightens neuronal vulnerability. Lipid rafts also facilitate receptor-mediated signaling, tying lipid imbalances to immune activation. Consequently, therapeutic strategies targeting lipid pathways are gaining traction, including modulating apolipoprotein E, inhibiting ceramide synthesis, and supplementing fatty acids to enhance membrane fluidity. Moreover, lipidomics helps identify unique lipid signatures that could serve as biomarkers for early diagnosis and treatment monitoring. Understanding the connection between lipid metabolism, neuroinflammation, and neurodegeneration offers valuable insights for developing targeted interventions in neurodegenerative diseases.
    Keywords:  Aging; Alzheimer's disease; Lipid metabolism; Lipid rafts; Neurodegeneration; Neuroinflammation
    DOI:  https://doi.org/10.1016/j.arr.2026.103114
  9. Proc Natl Acad Sci U S A. 2026 Apr 07. 123(14): e2527009123
      Traumatic brain injury (TBI) is a leading cause of morbidity and mortality, with closed-head mild TBI (mTBI) accounting for nearly 90% of all cases. Early pathological events include microglial activation and neuronal mitochondrial dysfunction; however, their interconnection in mTBI remains poorly understood. Using a clinically relevant closed-head weight-drop mouse model, we identified mitochondrial DNA (mtDNA)-specific damage and increased expression of innate inflammatory markers (IL-1α/β, IL-6, TNFα, and CXCL1) in the cerebral cortex during the acute mTBI phase. Mechanistically, neurons subjected to in vitro injury model of mTBI exhibited early mtDNA-specific damage followed by mtDNA release via extracellular vesicles (EVs) together with the neuronal and exosomal markers. The released neuronal mtDNA induced a robust microglial activation mediated by binding to the cytoplasmic DNA/RNA sensor Z-DNA-binding protein 1 (ZBP1), triggering activation of the ZBP1-TBK1-IRF3 pathway resulted IL-6 and TNFα expression. An early, enhanced amounts of mtDNA, neuronal and exosomal markers were measured in EVs circulating in the blood of mice subjected to mTBI. ZBP1 knockout (KO) mice displayed suppressed microglial-but not astrocytic-activation in the cortex during the acute mTBI phase. We also measured accumulation of mtDNA-specific damage in the hippocampus during the postacute mTBI phase. The absence of microglial activation in ZBP1 KO mice exacerbated hippocampal-related memory deficits in the postacute mTBI phase. Collectively, our findings identify mtDNA-ZBP1 signaling as a key mechanism regulating microglial activation in mTBI.
    Keywords:  Z DNA binding protein 1; microglia; mild traumatic brain injury; mitochondrial DNA; neuroinflammation
    DOI:  https://doi.org/10.1073/pnas.2527009123
  10. JCI Insight. 2026 Apr 02. pii: e201466. [Epub ahead of print]
      Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded polyglutamine (CAG) repeat in the N-terminal of the Huntingtin protein (HTT). Microglial activation and elevated pro-inflammatory cytokines are observed in HD brains, but the mechanisms regulating neuroinflammation and microglial activation are poorly understood. Metformin-mediated neuroprotection has been demonstrated in experimental models of neurodegeneration, including HD. We found that metformin inhibits mitochondrial DNA (mtDNA) release and subsequent neuroinflammation in the cortex and striatum of a mouse model of HD. Moreover, elevated pro-inflammatory cytokines and microglial activation are inhibited by metformin in HD transgenic mice brain. Metformin reduced pathological microglial clusters and shifted towards a quiescent, homeostatic phenotype. Metformin improved aberrant immunometabolism in HD mouse brain and primary microglia. Mechanistically found that metformin regulates mitochondrial fission, reprograms deregulated metabolism in HD microglia, and controls microglial activation and inflammation in HD transgenic mice.
    Keywords:  Glucose metabolism; Metabolism; Neurodegeneration; Neuroscience
    DOI:  https://doi.org/10.1172/jci.insight.201466
  11. J Alzheimers Dis. 2026 Apr 03. 13872877261437264
      BackgroundThe postnatal maturation of microglia is essential for neural circuit refinement, yet its molecular regulators remain incompletely defined. TREM2, a key Alzheimer's disease risk gene, is implicated in microglial function, but its role in developmental timing is unclear.ObjectiveTo determine whether TREM2 regulates the postnatal maturation of microglia and to assess the cellular, molecular, and behavioral consequences of TREM2 deficiency.MethodsWe performed longitudinal transcriptomic profiling of Trem2-knockout and control microglia. Morphological analyses were conducted alongside evaluation of synaptic pruning from postnatal day 7, 14, and 21. Adult mice were behaviorally tested at baseline and after immune challenge.ResultsTrem2-knockout disrupted stage-specific transcriptional programs, decoupled PRC2 subunit expression, and impaired repression of early developmental genes. This dysregulation coincided with persistent mitochondrial and metabolic deficits. Trem2-knockout microglia exhibited simplified morphology, reduced density, and impaired synaptic pruning, leading to excessive synaptic retention. In adulthood, these mice displayed heightened anxiety-like and repetitive behaviors, which worsened after immune challenge.ConclusionsOur study identifies TREM2 as a regulator of microglial developmental timing and links aberrant postnatal microglial maturation to lifelong behavioral vulnerabilities, providing mechanistic insight into neurodevelopmental risk.
    Keywords:  Alzheimer's disease; anxiety; development; microglia; risk gene; synapse; transcriptomics
    DOI:  https://doi.org/10.1177/13872877261437264
  12. bioRxiv. 2026 Mar 27. pii: 2026.03.25.714174. [Epub ahead of print]
      Elucidating how normal aging increases vulnerability to neurodegeneration remains a major gap in our understanding of disease risk and progression. The dorsal striatum serves as the primary input nucleus of the basal ganglia and is a key region implicated in multiple neurodegenerative diseases (NDDs) (1). In Colon et al. 2025 (2), we examined the impact of normal aging on neuroinflammatory signaling and perineuronal net (PNN) homeostasis within the dorsal striatum. We observed age-associated shifts in the inflammatory landscape and evidence of increased microglial activation, yet PNN homeostasis was largely preserved (2). PNNs are highly organized extracellular matrix (ECM) specializations that preferentially enwrap the soma and proximal dendrites of fast-spiking GABAergic parvalbumin (PV) interneurons, where they contribute to the regulation of synaptic plasticity and provide protection against oxidative stress (3,4). Building on these findings, we developed a working hypothesis to explain the apparent preservation of PNN homeostasis despite an aging-associated pro-inflammatory environment. The shift toward a pro-inflammatory milieu, together with increased gliosis and phagocytic activity, would be expected to impact the maintenance and integrity of perineuronal nets. The observed increase in phagocytosis-related markers may reflect microglia-directed activity as well as contributions from additional central nervous system (CNS) cell populations. Microglia are specialized embryonic-derived myeloid cells that serve as the resident immune cells of the brain and contribute to PNN homeostasis under physiological conditions (5). In Colon et al. 2025, we observed evidence of microgliosis (e.g., morphological changes, Iba1, Trem2 ) along with elevated expression of markers associated with phagocytosis (e.g., Cd68 ) and extracellular matrix-modifying proteases (e.g., Mmp9, Adam17 ) capable of cleaving key PNN components (2). Importantly, Cd68 expression is not exclusive to microglia and has been detected in brain infiltrating macrophages, reactive astrocytes, and neutrophils during inflammation (6-8). Thus, increased Cd68 levels may not solely reflect microglial phagocytic activation but may also reflect astrocyte reactivity and phagocytic phenotypes. Furthermore, astrocytes are the most abundant glial cell in the brain, and they play a major role in maintaining CNS homeostasis by regulating extracellular neurotransmitter concentrations, providing metabolic support, contributing to the synthesis and remodeling of PNN components, and modulating neuronal communication through their involvement in the tetrapartite synapse (9-12). Astrocytes can also phagocytosis microglial debris, myelin, and synapses (7). To better define the cellular source of phagocytic activity and its relationship to PNN remodeling in aging, we performed immunostaining for microglia (Iba1 + ), astrocytes (GFAP + ), phagolysosomal activity (CD68 + ), and PNNs using Wisteria floribunda agglutinin (WFA + ), enabling us to assess the spatial relationship between phagocytosis and PNN components.
    DOI:  https://doi.org/10.64898/2026.03.25.714174
  13. Transl Psychiatry. 2026 Mar 31. pii: 224. [Epub ahead of print]16(1):
      The rare APOE3-Christchurch (APOE3Ch) variant is linked to resistance against PSEN1 p.E280A-driven autosomal dominant Alzheimer's disease (AD). Recent studies in AD mouse models have demonstrated an effect of APOE3Ch in reducing tau pathology and tau propagation, yet its effects on amyloid pathology and related toxicity are not fully understood. While prior studies have reported reduced amyloid pathology with APOE3Ch, we extended this knowledge by investigating how astrocyte-specific expression of APOE3Ch impacts amyloid pathology and related responses in 5xFAD mice, an amyloid mouse model. Using adeno-associated virus (AAV)-mediated gene delivery, we overexpressed APOE3 or APOE3Ch in astrocytes of 5xFAD mice at the neonatal stage, then analyzed their effects during the advanced stage of amyloid pathology. Astrocytic APOE expression significantly reduced amyloid burden, neuritic dystrophy, and gliosis compared to GFP controls. Notably, astrocytic APOE3Ch expression, relative to APOE3, markedly lowered oligomeric Aβ levels and promoted the formation of more compact, fibrillar plaques, suggesting a shift toward a less toxic aggregation profile. Transcriptomic profiling of cortical tissue revealed broad downregulation of immune-related and proteostatic pathways. These findings indicate that astrocytic APOE3Ch sufficiently attenuates Aβ pathology and related toxicity, supporting its potential as a therapeutic modifier for AD.
    DOI:  https://doi.org/10.1038/s41398-026-04002-9
  14. Acta Neurol Belg. 2026 Apr 01.
      
    Keywords:  Amyloid; Neuroinflammation; Non-Alzheimer’s dementia; Plasma biomarkers; Soluble TREM2; Tau
    DOI:  https://doi.org/10.1007/s13760-026-03042-8
  15. J Neurochem. 2026 Apr;170(4): e70414
      Recent advances, including single-cell transcriptomics, lineage tracing, and in vivo imaging, have unveiled the heterogeneity, plasticity, and functional versatility of astrocytes, microglia, oligodendrocytes, and Schwann cells. These cells respond to metabolic and immune cues, participate in synaptic regulation, and provide metabolic and trophic support to neurons. Their dual roles in neuroprotection and neurodegeneration underscore the complexity of their contributions across CNS disorders. This review examines the diverse physiological and pathological roles of glia, emphasizing their involvement in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Mechanisms including metabolic dysfunction, inflammatory polarization, glial-immune crosstalk, and extracellular vesicle-mediated signaling are critically discussed. Emerging therapeutic strategies, ranging from glial reprogramming and senolytic therapies to the use of engineered extracellular vesicles and metabolic modulators, are evaluated for their potential to harness glial plasticity and mitigate disease progression. The review also outlines current challenges in translating glial biology into clinical interventions, including cellular heterogeneity, delivery barriers, and the need for specific biomarkers. A glia-centered therapeutic paradigm offers promising avenues to restore CNS homeostasis and promote regeneration in neurodegenerative diseases.
    DOI:  https://doi.org/10.1111/jnc.70414
  16. Nat Aging. 2026 Apr 03.
      The full impact of APOE4 (apolipoprotein E4), the strongest genetic risk factor for Alzheimer's disease (AD), on neuronal and network function remains unclear, particularly during early preclinical stages of disease. Here we show that young APOE4 knockin (E4-KI) mice exhibit hippocampal region-specific network hyperexcitability that predicts later cognitive deficits. This early phenotype arises from cell-type-specific subpopulations of smaller, hyperexcitable neurons and is eliminated by selective removal of neuronal APOE4. With aging, E4-KI mice develop granule cell hyperexcitability, progressive inhibitory dysfunction and excitation-inhibition imbalance in the dentate gyrus. Single-nucleus RNA sequencing with multilevel gene filtering reveals age-dependent and cell-type-specific transcriptional changes and identifies candidate mediators of early neuronal hyperexcitability, including Nell2. Targeted CRISPR interference knockdown of Nell2 rescues abnormal excitability, implicating Nell2 as a contributor to APOE4-driven dysfunction. Together, these findings define molecular and circuit mechanisms linking neuronal APOE4-induced early network impairment to AD pathogenesis with aging.
    DOI:  https://doi.org/10.1038/s43587-026-01096-0
  17. J Integr Neurosci. 2026 Mar 16. 25(3): 47039
       BACKGROUND: A high-fat diet (HFD) has been implicated in the induction of depressive-like behaviors, yet the underlying mechanisms remain incompletely elucidated. Growing evidence indicates that microglia-mediated neuroinflammation plays a critical role in the pathogenesis of depression, with excessive lipid droplet (LD) accumulation emerging as an early trigger for neuroinflammatory cascades. The aim of this study was to investigate microglial LD accumulation and the associated neuroinflammatory response in a model of HFD-induced depression.
    METHODS: Diet-induced obese (DIO) mice were compared with normal control (Con) mice. Depressive-like behaviors were evaluated through a battery of behavioral tests. Hippocampal neuronal damage and microglial activation were assessed using histological and immunofluorescence techniques. A co-culture system of glial cell-enriched isolates and hippocampal neurons was employed to evaluate the neurotoxic potential of DIO microglia. LD accumulation in microglia was quantified in vivo and in vitro using Bodipy staining, Oil Red O staining, and electron microscopy. Untargeted lipidomics was performed on glial cells to characterize alterations in lipid metabolism.
    RESULTS: Compared with Con mice, DIO mice exhibited significant depressive-like behaviors and hippocampal neuronal damage, accompanied by enhanced microglia-mediated neuroinflammation. In the co-culture system, microglia from DIO mice demonstrated increased neurotoxicity toward hippocampal neurons. Bodipy staining and electron microscopy revealed increased accumulation of LDs in the hippocampal microglia of DIO mice. This was further confirmed in glial cells in vitro. Lipidomic profiling identified substantial disturbances in lipid metabolism in DIO microglia.
    CONCLUSION: Diet-induced obesity leads to depressive-like behaviors and hippocampal neuronal damage, which is associated with microglia-mediated neuroinflammation and intracellular accumulation of LDs. The enhanced neurotoxicity of DIO microglia, coupled with pronounced lipid metabolic dysregulation, suggests that lipid-laden microglia may contribute to the link between obesity and depression via neuroinflammatory mechanisms.
    Keywords:  depression disorder; lipid droplet; microglia; neuroinflammation diseases; obesity
    DOI:  https://doi.org/10.31083/JIN47039
  18. Neuroscience. 2026 Mar 28. pii: S0306-4522(26)00221-6. [Epub ahead of print]603 201-213
      Microglia play a major role in the pathophysiology of Parkinson's disease, where they regulate both α-synuclein (αSyn) aggregate clearance and inflammatory responses. Interferon gamma (IFNγ) is a strong immunomodulator, but its role in shaping human microglial phenotypes during αSyn exposure remains incompletely understood. Further, whether the secreted factors from microglia after exposure to αSyn pre-formed fibrils (PFFs) and IFNγ can affect morphology and functionality of dopaminergic neurons has not been studied. We used human stem cell-derived microglia to investigate how αSyn PFFs and IFNγ stimulation influence microglial metabolism, lipid composition, and phenotypic state. IFNγ induced broad metabolic and lipidomic remodeling, affecting glycolytic, tryptophan, and phospholipid pathways. Pre-exposure to IFNγ promoted a resolving-like phenotype upon αSyn PFFs challenge, characterized by increased transglutaminase 2 (TGM2) expression and elevated TGFβ1 secretion. Conditioned media (CM) from exposed microglia were applied to human iPSC-derived dopaminergic neurons, and neuronal morphology, protein expression, mitochondrial function, and electrophysiological activity were evaluated. CM from αSyn PFFs-exposed microglia reduced neuronal branching and neurite length. Furthermore, CM from stimulated microglia decreased TUJ1 and TH expression, altered mitochondrial regulators (cytochrome C, MnSOD, iNOS), and disrupted neuronal activity as measured by changes in c-FOS expression and multielectrode array recordings. IFNγ profoundly modulates human microglial states, enhancing resolving-like features and simultaneously driving secretome-mediated neuronal effects. These findings highlight microglial activation state as a critical determinant of neuronal vulnerability in αSyn-associated pathology. Importantly, IFNγ-induced microglial activation can, at least partially, counteract αSyn-driven adverse effects on dopaminergic neurons.
    Keywords:  Alpha-synuclein; Dopaminergic neurons; Interferon-gamma; Lipidomics; Metabolomics; Microglia
    DOI:  https://doi.org/10.1016/j.neuroscience.2026.03.040
  19. Nat Commun. 2026 Apr 01.
      Gastrointestinal dysfunction often precedes motor symptoms in Parkinson's disease (PD), suggesting the enteric nervous system (ENS) is central to early pathogenesis. How α-synuclein contributes to ENS dysfunction, and how inflammation modulates this, remains unclear. Here we show that Tumor Necrosis Factor alpha enhances α-synuclein accumulation in induced pluripotent stem cell-derived enteric neurons and glia, and impairs the malate-aspartate shuttle, a key pathway for mitochondrial energy production. This drives a metabolic shift toward glutamine oxidation in patient cells. This metabolic impairment reduces overall mitochondrial function, which is partially rescued by the neuroprotective compound Chicago-Sky-Blue 6B. Furthermore, transcriptomic and histological analyses of human gut tissue from inflammatory bowel disease patients reveal that inflammation-associated metabolic suppression and α-synuclein upregulation occur beyond PD, representing general hallmarks of intestinal inflammation. These findings highlight a conserved metabolic vulnerability in the ENS and establish patient-derived enteric lineages as a robust platform to model inflammatory ENS pathology.
    DOI:  https://doi.org/10.1038/s41467-026-71317-y
  20. Eur J Neurosci. 2026 Apr;63(7): e70480
      Synapse loss is the strongest pathological correlate of cognitive decline in Alzheimer's disease (AD) and is most pronounced around amyloid plaque pathology in the brain. Although mechanisms remain incompletely understood, hyperactivity downstream of soluble amyloid beta (Aβ) is strongly implicated in synapse degeneration. Engulfment of synapses by reactive astrocytes was observed in end-stage disease tissue, particularly around plaques. Due to astrocytes' role in synaptic modulation, we hypothesised that astrocytes could modulate synapse degeneration downstream of soluble Aβ earlier in disease pathogenesis. To test this, we challenged organotypic mouse brain slices with human AD brain homogenates containing Aβ. Changes in synaptic activity were detected 2 h after Aβ challenge, and spine loss was seen after 24 h. We observe that Aβ-containing homogenate induces a significant loss of spines compared with controls. Aβ-containing homogenate also causes a significant increase in the frequency of synaptic calcium events, particularly in synapses lost at 24 h. Dendritic spines associated with astrocytic processes were significantly more likely to survive at 24 h after Aβ challenge and had reduced levels of externalised phosphatidyl serine despite no effect of astrocyte proximity on synaptic activity. Inhibiting astrocytic glutamate transporters prevented the protective effects of astrocytes on synapses, indicating that astrocytes are protective of synapses at least in part through removing excess glutamate from the synaptic microenvironment. Our findings suggest that an organotypic mouse brain slice model challenged with disease tissue homogenates effectively recapitulates key features of early AD, including synapse loss and hyperexcitability. Moreover, they indicate that astrocytes play a protective role in preserving synapses, particularly during short-term exposure to low concentrations of toxic Aβ. Future work is needed to elucidate the role of astrocyte-mediated synapse phagocytosis in response to chronic Aβ exposure.
    Keywords:  Alzheimer's disease; Aβ; astrocytes; synapse; synapse loss
    DOI:  https://doi.org/10.1111/ejn.70480
  21. Phytother Res. 2026 Mar 28.
      Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by a preclinical stage that typically lasts for decades. Early on during this time, microglia react to pathological changes and become protective and even transiently delay neurodegeneration. In contrast, microglia later acquire the typical pro-inflammatory features that contribute to neurodegeneration in advanced disease. Such decades-long time frame is marked by a significant vulnerability to any event able to tip the balance toward inflammatory microglia. Increasing evidence suggests that early life hypoxic events could be risk factors for AD by acting as early triggers of microglial phenotypic transition, especially affecting mitochondrial functions and energy balance. The NAD+-dependent deacetylase SIRT1 could be a valuable target in this context for its anti-inflammatory and anti-aging functions, which include direct modulation of mitochondrial homeostasis. Many natural compounds enriched in Mediterranean diet foods, such as citrus and olives, could prove protective by inducing SIRT1 and therefore both reducing neuroinflammation and promoting mitochondrial health. This would be in line with data reporting how the type of diet can affect AD risk. Based on these premises, we here discuss the links between hypoxia, neuroinflammation, energy imbalance and mitochondrial alterations. We will describe how SIRT1 can represent a key molecular link and an appealing target to harness microglial neuroprotective potential as a preventive strategy during the key time frame of pre-symptomatic AD. We conclude with a brief summary of the up-to-date evidence on the benefits of natural SIRT1 inducers that act on the inflammation-energy axis.
    Keywords:  Alzheimer's disease; Mediterranean diet; hypoxia; mitochondria; natural SIRT1‐inducers; neuroinflammation
    DOI:  https://doi.org/10.1002/ptr.70317
  22. Biochem Biophys Res Commun. 2026 Mar 23. pii: S0006-291X(26)00421-3. [Epub ahead of print]815 153657
      CX3CR1-Cre mouse lines have produced important advancements in our understanding of microglial biology. Recent studies have demonstrated the adverse effects of tamoxifen-induced CX3CR1-Cre expression during development, which may include changes in microglial density, phenotype, and DNA damage, as well as anxiety-like behavior. However, the unintended effects of constitutive CX3CR1-BAC-Cre expression remain unexplored. Here, we characterized the effects of CX3CR1-BAC-Cre expression on microglia in CX3CR1-BAC-Cre +/- and CX3CR1-BAC-Cre-/- male and female littermates during early postnatal development and adulthood in multiple brain regions. Additionally, we performed anxiety-like behavior tests to assess changes caused by Cre expression. We found that CX3CR1-BAC-Cre expression causes subtle region-and sex-specific changes in microglial density, volume, and morphology during development, but these changes normalized by adulthood in all brain regions except the hippocampus. No behavioral changes were identified. Our findings suggest that the constitutive-Cre model is less detrimental than the inducible model, and highlight the need for proper controls.
    Keywords:  Anxiety-like behavior; Brain development; Constitutive CX3CR1-Cre; IBA1; Microglia; P2RY12
    DOI:  https://doi.org/10.1016/j.bbrc.2026.153657
  23. J Clin Invest. 2026 Apr 01. pii: e199845. [Epub ahead of print]136(7):
      Lysosomes function as metabolic control centers that integrate degradation, nutrient sensing, and stress signaling. In neurons, which must maintain proteostasis and energetic balance throughout life, lysosomal homeostasis determines cellular resilience. Emerging evidence identifies lysosomal injury and defective repair as common denominators across neurodegenerative diseases. Damage to the lysosomal membrane caused by oxidative stress, lipid imbalance, or genetic mutations triggers a hierarchical quality control cascade. Early lesions recruit the endosomal sorting complex required for transport (ESCRT) machinery for mechanical resealing, while larger ruptures activate lipid-centered recovery modules. When repair fails, lysophagy eliminates irreparable organelles and a TFEB-dependent transcriptional program regenerates the lysosomal pool. These tightly coupled responses safeguard neurons from catastrophic proteostatic collapse. Their impairment, through mutations in lysosomal proteins, or through aging, produces the lysosomal fragility that underlies Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis/frontotemporal dementia, and Huntington disease. Crosstalk between lysosomes, mitochondria, and ER integrates local damage with systemic metabolic adaptation, while dysregulated lysosomal exocytosis and inflammation propagate pathology. Understanding how ESCRT complexes, lipid transport, and transcriptional renewal cooperate to preserve lysosomal integrity reveals unifying principles of neurodegeneration and defines molecular targets for intervention. Restoring lysosomal repair and renewal offers a rational path toward preventing neuronal loss.
    DOI:  https://doi.org/10.1172/JCI199845
  24. J Clin Invest. 2026 Apr 02. pii: e196112. [Epub ahead of print]
      Traumatic brain injury (TBI) disproportionately affects the elderly, yet the underlying mechanisms remain unclear. Here, we demonstrate that aged TBI brains predominantly harbor pro-inflammatory NLRP3+ microglia, in stark contrast to the neuroprotective Lysozyme+ microglia prevalent in young TBI brains. This age-dependent microglial dichotomy correlates with elevated mortality and impaired recovery in aged TBI mice. By leveraging an integrative multi-omics approach combined with metabolomics and epigenome analysis, we identify a previously unrecognized link between enhanced glycolysis and pro-inflammatory chromatin landscape in NLRP3+ microglia. Further investigation identifies ELF1 as a key transcription factor driving NLRP3+ microglia formation. Importantly, ablation of ELF1 reverses age-associated microglial dysfunction and improves TBI outcomes. Finally, we discover that Imeglimin, a clinically approved antihyperglycemic agent capable of crossing the blood brain barrier, inhibits ELF1 and reverses microglial phenotype, reducing acute mortality rate and leading to improved functional recovery of aged TBI mice. Our work elucidates the mechanistic basis of age-dependent TBI outcomes, reveals the crosstalk between metabolic rewiring and epigenetic regulation in microglial aging, and identifies ELF1 as a promising therapeutic target for improving TBI outcome.
    Keywords:  Drug therapy; Immunology; Inflammation; Innate immunity; Neurodegeneration; Neuroscience
    DOI:  https://doi.org/10.1172/JCI196112
  25. Neuron. 2026 Mar 30. pii: S0896-6273(26)00132-7. [Epub ahead of print]
      Memory-based cognition relies on the integrity of cortico-hippocampal circuits, which are compromised in Alzheimer's disease (AD) as β-amyloid (Aβ) and tau accumulate. However, the mechanisms linking this pathology to circuit dysfunction remain unclear. In mouse models, using in vivo two-photon and Neuropixels recordings, we show that Aβ-tau pathology promotes both region- and layer-specific impairments, involving reduced burst firing in superficial cortical layers and CA1 and reduced mean firing of excitatory and inhibitory neurons in deep cortical layers and CA1. Exposure to Aβ primed the susceptibility of neuronal populations to tau-induced impairment. Combined Aβ-tau reduced synaptic NMDA receptor (NMDAR) density in both mouse and human tissue, while Aβ-tau co-reduction restored NMDARs and firing patterns and improved contextual memory. NMDAR antagonism in healthy mice phenocopied regional and laminar deficits. Our findings implicate synaptic NMDAR hypofunction as a reversible mechanism linking Aβ-tau synergy to cortico-hippocampal dysfunction in AD.
    Keywords:  Alzheimer’s disease; NMDARs; Neuropixels; cortical layers; cortico-hippocampal circuits; memory impairment; neurodegeneration; synaptic dysfunction; tau; two-photon calcium imaging; β-amyloid
    DOI:  https://doi.org/10.1016/j.neuron.2026.02.027
  26. J Neurosci. 2026 Mar 31. pii: e1904252026. [Epub ahead of print]
      Aging is the primary risk factor for Parkinson's disease (PD) and PD-related cognitive impairment remains a major unmet biomedical challenge. Klotho, a pleiotropic protein, extends lifespan and enhances cognition, but whether it confers resilience to cognitive impairments in PD is unclear. Here, we show that in humans, the KL-VS genetic variant of KLOTHO, linked to higher circulating klotho levels, associated with better executive cognition in individuals with PD across two independent cohorts. To test causality and explore mechanisms, we turned to mouse models. Transgenic elevation of klotho in a mouse model increased lifespan, improved synaptic and cognitive, but not motor, functions in mice, and decreased steady state α-synuclein (α-syn) levels in the brains of male mice expressing wildtype human α-syn. Complementary in vitro studies showed that klotho rescued α-syn-induced deficits in NMDAR-dependent signaling through GluN2B and augmented α-syn microglial-related uptake, suggesting a potential mechanism by which klotho counters PD-related toxicity. Together, these findings indicate that klotho can counteract cognitive deficits related to PD, possibly by modulating α-syn levels - and these findings may be relevant to new therapeutic pathways for PD.Significance statement Klotho is a longevity factor that improves cognition in old mice, Alzheimer's disease model mice, and old nonhuman primates, yet its role Parkinson's disease (PD)-related cognitive impairment remains unclear. Here, we identified an association between a KLOTHO variant and executive cognitive function in PD, a cognitive domain preferentially affected by the disease. To investigate biological mechanisms of klotho, we leveraged an α-synuclein mouse model of PD and found that klotho decreased cognitive deficits, potentially by increasing synaptic plasticity and reducing α-synuclein levels. Together, these findings suggest that klotho modulates PD-related cognitive deficits and highlight klotho-based strategies as promising therapeutic pathways for cognitive impairment in PD and other α-synucleinopathies.
    DOI:  https://doi.org/10.1523/JNEUROSCI.1904-25.2026
  27. Biophys J. 2026 Apr 02. pii: S0006-3495(26)00264-X. [Epub ahead of print]
      Alzheimer's disease (AD) is associated with the extracellular accumulation of neurotoxic Aβ-peptides in the brain. Aβ-peptides are produced via an amyloid precursor protein (APP) cleavage pathway that is initiated by the β-secretase. The majority of APP circumvents the amyloidogenic pathway due to α-secretase cleavage at the plasma membrane. In this study, we set out to identify potential mechanisms limiting α-cleavage. We employed isolated cell membranes to study α-secretase cleavage in the absence of APP delivery to the plasma membrane and internalization. We distinguish a readily cleavable and a cleavage-resistant APP pool. The cleavage-resistant and most likely immobile APP pool is organized in clusters and by this could escape the amyloidogenic pathway. In sum, our results identify that α-secretase cleavage at the plasma membrane occurs rapidly though in an incomplete manner due to the presence of cleavage-resistant APP clusters.
    DOI:  https://doi.org/10.1016/j.bpj.2026.03.061
  28. Alzheimers Res Ther. 2026 Mar 28.
      
    Keywords:  ARIA; Alzheimer’s disease; Amyloid-related imaging abnormalities; Amyloid-targeting therapies; Cerebral amyloid angiopathy; Dementia; Neurodegeneration; Neuroinflammation
    DOI:  https://doi.org/10.1186/s13195-026-02022-7
  29. Nature. 2026 Apr 01.
      Neurodegeneration shows regional and cell-type-specific patterns in ageing and disease1, but the underlying mechanisms for cell-type-specific neuronal losses remain poorly understood. Previous studies have shown that upper cortical layer thinning occurs in progressive human multiple sclerosis (MS) and that cortical layer 2 and layer 3 (L2/3) excitatory neurons (L2/3ENs) that express CUT-like homeobox 2 (CUX2) are selectively vulnerable to degeneration2. Here we report that L2/3ENs within MS cortical lesions have an elevated DNA damage burden. DNA damage and selective loss of L2/3ENs were recapitulated in diverse mouse models of demyelination and pan-cortical inflammation, confirming their intrinsic vulnerability. Functions of Cux2 and activating transcription factor 4 (Atf4) were essential for resilience of L2/3ENs during postnatal neuroinflammation, acting in neurons to enhance DNA double-strand break repair. Interferon-γ, a cytokine implicated in MS pathogenesis3,4, was sufficient to elevate levels of reactive oxygen species, leading to DNA damage-mediated neuronal death in vitro, and caused selective depletion of L2/3 neurons in mice. These findings indicate that DNA damage burden and inadequate repair in CUX2+ L2/3ENs contributes to selective vulnerability in neuroinflammatory injury.
    DOI:  https://doi.org/10.1038/s41586-026-10310-3